← FDA DRUG APPROVALS

FDA NDA · NDA007413

PROTAMINE SULFATE

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
NDA007413
TYPE
NDA
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

PROTAMINE SULFATEDiscontinued
PROTAMINE SULFATE 50MG/VIAL · POWDER · INTRAVENOUS
PROTAMINE SULFATEDiscontinued
PROTAMINE SULFATE 250MG/VIAL · POWDER · INTRAVENOUS
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →